Results 181 to 190 of about 103,562 (296)

Association between oral microbial shifts and polycystic ovary syndrome: a systematic review. [PDF]

J Oral Microbiol
Mao Q, Liu C, Yan Z.
europepmc   +1 more source

Kefir: A Potential Gut Microbiota Modulator: A Systematic Review of Human Interventional Studies

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Daily cow's milk kefir intake transiently enriches gut microbiota, modulates the intestinal environment by increasing SCFA and reducing pH and oxygen, and exerts antimicrobial effects via SCFAs, bacteriocins, exopolysaccharides, and microbial fractions, highlighting its potential for gut health promotion.
Mohammed Hamsho, Yazan Ranneh, Batoul Kaddour, Sundus Alfakhri, Hale Hacıbayram, Wijdan Shkorfu, Merve Terzi, Abdulmannan Fadel   +7 more
wiley   +1 more source

Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. [PDF]

J Ovarian Res
Dashti S, Ashouri A, Bahri N.
europepmc   +1 more source

Metformin as a Multifaceted Therapeutic Agent for Gastrointestinal Diseases: Mechanisms, Clinical Efficacy, and Future Directions

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT The high prevalence of gastrointestinal (GI) diseases and their significant impact on the quality of life require new therapeutic strategies. The development of novel therapeutic strategies should prioritize targeting the fundamental pathophysiological mechanisms underlying these diseases, including inflammation, cellular proliferation, and ...
Sayedeh Azimeh Hosseini, Hassan Valadbeigi, Seyedeh Mahdieh Khoshnazar, Saeed Khoshnood, Shahab Falahi, Delsuz Rezaee, Ali Hematian, Mohammad Hossein Haddadi   +7 more
wiley   +1 more source

Implementing a Co‐Produced Women's Health Programme in an Integrated Care System

Public Health Challenges, Volume 5, Issue 2, June 2026.
A co‐produced women's health programme is implemented within an integrated care system using a structured, six‐phase service improvement approach. Engagement with over 1200 participants identifies barriers, priorities, and service gaps. Findings inform the co‐design of five targeted service models.
Susan Conquer, Lizzie Mapplebeck, Annetta Bradshaw, Lisa Nobes, Camille Cronin   +4 more
wiley   +1 more source

Lifestyle factors for polycystic ovary syndrome: a case-control study. [PDF]

J Ovarian Res
Huo X, Liu H, Nian M, Zhang J.
europepmc   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Polycystic Ovary Syndrome Revisited: Novel Insights and Updates. [PDF]

Int J Med Sci
Zhao W, Zhou J, Song Y, He M, Zhu X, Yu B, Gao W.   +6 more
europepmc   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna, Carlos Mena‐Hurtado, Victoria Divino, Zhenxiang Zhao, Yan Chen, Joanna Boland, Jinlin Song, Andrea Traina, Kerem Ozer, Filip K. Knop, Kim G. Smolderen   +10 more
wiley   +1 more source

Association between the diabetes risk reduction diet and polycystic ovary syndrome. [PDF]

BMC Nutr
Jamalvandi M, Fateh HL, Ahmadi T, Moludi J, Samadi M, Moradinazar M.   +5 more
europepmc   +1 more source